行情

XTLB

XTLB

X T L Bio
NASDAQ

实时行情|Nasdaq Last Sale

1.312
+0.002
+0.15%
休市 16:00 11/15 EST
开盘
1.320
昨收
1.310
最高
1.320
最低
1.312
成交量
200
成交额
--
52周最高
2.930
52周最低
1.250
市值
905.81万
市盈率(TTM)
2.187
分时
5日
1月
3月
1年
5年

EPS

XTLB 新闻

  • 约500万美国人有睡眠问题 手机可能是罪魁祸首
  • 新华国际.1小时前
  • 世界首富易主!比尔·盖茨反超亚马逊CEO贝佐斯登顶
  • 中国新闻网.1小时前
  • 苹果为什么不全面开放NFC?不愿改变Apple Pay现状
  • 新浪科技.2小时前
  • Twitter在2020年美国大选前收紧对政治广告的禁令
  • 新浪科技.3小时前

更多

所属板块

生物技术和医学研究
+1.25%
制药与医学研究
+1.34%

热门股票

名称
价格
涨跌幅

XTLB 简况

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
展开

Webull提供X T L Biopharmaceuticals Ltd (ADR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。